Business Segments · Goodwill (Note 3)
MEDTECH — Goodwill (Note 3)
Johnson & Johnson MEDTECH — Goodwill (Note 3) decreased by 0.2% to $33.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $33.56B to $33.75B. Over 4 years (FY 2021 to FY 2025), MEDTECH — Goodwill (Note 3) shows an upward trend with a 22.7% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 22, 2026
Rolls up toGoodwill
How to read this metric
An increase suggests recent acquisitions, while a decrease may indicate impairment charges or divestitures.
Detailed definition
Represents the total carrying value of goodwill allocated to the MedTech operating segment as reported in the financial...
Peer comparison
Standard across large-cap healthcare companies with M&A activity.
Metric ID:
jnj_segment_medtech_goodwill_note_3Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.93B | $14.86B | $14.86B | $14.91B | $14.99B | $14.95B | $25.86B | $26.03B | $26.04B | $25.98B | $26.15B | $26.06B | $33.48B | $33.69B | $33.51B | $33.56B | $33.79B | $33.78B | $33.81B | $33.75B |
| QoQ Change | — | -0.4% | -0.0% | +0.4% | +0.5% | -0.2% | +73.0% | +0.7% | +0.0% | -0.2% | +0.7% | -0.3% | +28.5% | +0.6% | -0.5% | +0.2% | +0.7% | -0.0% | +0.1% | -0.2% |
| YoY Change | — | — | — | — | +0.4% | +0.6% | +74.1% | +74.6% | +73.7% | +73.7% | +1.1% | +0.1% | +28.6% | +29.7% | +28.1% | +28.8% | +0.9% | +0.3% | +0.9% | +0.6% |
Range$14.86B – $33.81B
CAGR+18.7%
Avg YoY Growth+26.0%
Median YoY Growth+14.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — goodwill (note 3)?
- Johnson & Johnson (JNJ) reported medtech — goodwill (note 3) of $33.75B in Q1 2026.
- How has Johnson & Johnson's medtech — goodwill (note 3) changed year-over-year?
- Johnson & Johnson's medtech — goodwill (note 3) increased by 0.6% year-over-year, from $33.56B to $33.75B.
- What is the long-term trend for Johnson & Johnson's medtech — goodwill (note 3)?
- Over 4 years (2021 to 2025), Johnson & Johnson's medtech — goodwill (note 3) has grown at a 22.7% compound annual growth rate (CAGR), from $59.56B to $134.94B.
- What does medtech — goodwill (note 3) mean?
- The total value of intangible assets like brand reputation and customer relationships recorded for the MedTech segment.